Center of Excellence
Digital Therapeutics and Health Technology (DTxHT)
The most impactful and up-to-date value, access, reimbursement, and policy insights within the digital healthcare space.
Home / Centers of Excellence / Digital Therapeutics and Health Technology (DTxHT)
Digital health technologies are evolving rapidly and are playing an increasingly significant role in both the companion diagnostic and treatment paradigms. Trinity’s experts draw upon their deep understanding of access and reimbursement decision-making for traditional therapeutics to identify and analyze the most impactful events and landscape shifts in the digital space.
Trinity’s DTxHT knowledge resource hub releases regular up-to-date insights about policy updates, assessment routes, and funding pathways to support our clients in securing future strategic success. Some business challenges that we can support with include:
- Introducing new technologies that follow different funding pathways (e.g., self-pay, employer-sponsored, or public or private insurance funding)
- Understanding new HTA frameworks that evaluate the evidence supporting the effectiveness of digital health solutions
- Navigating the hurdles of proving the value of DTx through real-world-evidence
Follow Trinity on LinkedIn to receive exclusive updates that are native to the channel or read our latest thought leadership here.
Latest DTxHT Intelligence
Blog
Global Evidence Requirements to Launch a Digital Health Technology
In this article, Trinity analyzed existing guidelines and evaluation frameworks for digital health technologies, including mobile health (mHealth) applications, to identify key evidence requirements and areas that should be considered in the clinical assessment of digital health services.
Read More
Blog
Are Current Reimbursement Options for Opioid Use Disorder DTx Causing a Barrier to Widespread Adoption in the USA?
In 2020, Trinity assessed three applications developed to treat Opioid Use Disorders (OUD) (e.g., reSET-O, Connections, DynamiCare) through the lens of ICER conducting a cost-effectiveness evaluation. Only a year later, several more health tech startups have adopted a preventative outlook and seek to address chronic pain with digital health tools (e.g., phone applications) […]
Read More
Blog
ICER Released First Cost-Effectiveness Assessment for a Digital Therapeutic (DTx)
Three digital health technologies have been developed to treat opioid use disorder (OUD). These applications, reSET-O (Pear Therapeutics), Connections (Chess Health) and DynamiCare (DynamiCare Health) […]
Read More
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.